SQI Diagnostics

SQI Diagnostics is a precision medicine company dedicated to the discovery, development, and commercialization of innovative rapid diagnostic tests, thereby helping clinicians, patients, and consumers worldwide improve health outcomes. Our proprietary advanced diagnostic technologies target organ transplantation, autoimmune diseases, and serological testing, including the development of the direct-to-consumer COVID-19 HOME Antibody Test, RALI-Dx™ COVID-19 Severity Triage Test, and COVID-19 RALI-fast™ Severity Triage Point-of-Care (POC) Test. SQI’s rapid diagnostic tests are sold to healthcare professionals, enabling patients to receive accurate results and prompt, effective treatment, and are also available directly to consumers, allowing individuals to improve their health comfortably at home.